Cargando…
Fetal‐haemoglobin enhancing genotype at BCL11A reduces HbA(2) levels in patients with sickle cell anaemia
Understanding the interplay of genetic factors with haemoglobin expression and pathological processes in sickle cell disease is important for pharmacological and gene‐therapeutic interventions. In our nascent study cohort of Nigerian patients, we found that three major disease‐modifying factors, HbF...
Autores principales: | Adeyemo, Titilope A., Ojewunmi, Oyesola O., Oyetunji, Idayat Ajoke, Kalejaiye, Olufunto Olufela, Menzel, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175773/ https://www.ncbi.nlm.nih.gov/pubmed/35844678 http://dx.doi.org/10.1002/jha2.186 |
Ejemplares similares
-
A survey of genetic fetal-haemoglobin modifiers in Nigerian patients with sickle cell anaemia
por: Adeyemo, Titilope A., et al.
Publicado: (2018) -
Evaluation of high performance liquid chromatography (HPLC) pattern and prevalence of beta-thalassaemia trait among sickle cell disease patients in Lagos, Nigeria
por: Adeyemo, Titilope, et al.
Publicado: (2014) -
Association of alpha‐thalassemia and Glucose‐6‐Phosphate Dehydrogenase deficiency with transcranial Doppler ultrasonography in Nigerian children with sickle cell anemia
por: Ojewunmi, Oyesola Oyewole, et al.
Publicado: (2021) -
Ovarian reserve in nigerian women with sickle cell anaemia: a cross- sectional study
por: Garba, Sunusi Rimi, et al.
Publicado: (2021) -
FOETAL HAEMOGLOBIN (HbF) STATUS IN ADULT SICKLE CELL ANAEMIA PATIENTS IN IBADAN, NIGERIA
por: Olaniyi, J.A., et al.
Publicado: (2010)